JUAN M BAUTISTA
Allopathic & Osteopathic Physicians|Family Medicine TUCSON, AZ NPI 1619255007
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine AZ ABBVIE INC. All categories
General Payments — all program years on this page
$5,815.11
- Category: General Payments
- Program years: PY2019–2024
- Record count: 333
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,864.57 across 102 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,864.57 | 102 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $330.58 | 19 |
| Lilly USA, LLC | $228.88 | 13 |
| Acerta Pharma LLC | $221.65 | 7 |
| GlaxoSmithKline, LLC. | $180.42 | 12 |
| Amgen Inc. | $168.07 | 11 |
| PFIZER INC. | $114.85 | 7 |
| Radius Health, Inc. | $76.99 | 4 |
| AIMMUNE THERAPEUTICS, INC. | $61.81 | 4 |
| Novo Nordisk AS | $56.97 | 3 |
| Corcept Therapeutics | $38.67 | 2 |
| SANOFI-AVENTIS U.S. LLC | $34.40 | 1 |
| Astellas Pharma US Inc | $34.25 | 2 |
| Merck Sharp & Dohme Corporation | $33.87 | 2 |
| Ascendis Pharma Inc | $25.57 | 1 |
| Nevro Corp. | $23.35 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $22.23 | 1 |
| MannKind Corporation | $22.17 | 1 |
| Insulet Corporation | $20.52 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $19.31 | 1 |
| Mylan Specialty L.P. | $19.25 | 1 |
| Antares Pharma, Inc. | $18.52 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $18.50 | 1 |
| Lundbeck LLC | $18.25 | 1 |
| EISAI INC. | $17.11 | 1 |
| Almatica Pharma Inc. | $15.94 | 1 |
| Abbott Laboratories | $15.53 | 1 |
| Exact Sciences Corporation | $14.13 | 1 |
| INOGEN, INC. | $12.78 | 1 |
By program year
Records — PY2024 (102)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.